Skip to main content
. Author manuscript; available in PMC: 2011 Jun 30.
Published in final edited form as: N Engl J Med. 2010 Nov 23;363(27):2587–2599. doi: 10.1056/NEJMoa1011205

Figure 4. Levels of Study-Drug Components in Blood of Subjects Receiving FTC–TDF, According to HIV Status.

Figure 4

Shown are intracellular levels (Panels A and B) and plasma levels (Panels C and D) of components of emtricitabine and tenofovir disoproxil fumarate (FTC–TDF), quantified in specimens obtained from subjects in the FTC–TDF group. FTC-TP denotes emtricitabine triphosphate, and TFV-DP tenofovir diphosphate. The horizontal lines in each panel indicate medians.